rethinkPeptides Search
Menu
Study breakdown

Peptide Absorption Through the Gut Transporter hPEPT1: Drug Delivery Through the Intestine

evidence
The takeaway

Dipeptide affinity and translocation relationships via the intestinal peptide transporter hPEPT1 were characterized, guiding design of peptide-based oral drugs that exploit this gut absorption pathway.

Key finding

Dipeptide affinity and translocation relationships via the intestinal peptide transporter hPEPT1 were characterized, guiding design of peptide-based o

What the researchers found

Dipeptide affinity and translocation relationships via the intestinal peptide transporter hPEPT1 were characterized, guiding design of peptide-based oral drugs that exploit this gut absorption pathway.

Why it matters

Relevant for peptide research.

How the study worked

research study.

What this study cannot tell us

See abstract.

How to read the evidence

emerging evidence.

When this study was published

Published in 2011.

The bigger picture

Advances peptide research.

Questions still open

  • Further research needed.

Common questions

What was studied?
Peptide Absorption Through the Gut Transporter hPEPT1: Drug Delivery Through the Intestine
What was found?
Dipeptide affinity and translocation relationships via the intestinal peptide transporter hPEPT1 were characterized, guiding design of peptide-based oral drugs that exploit this gut absorption pathway.

Read the original research

Affinity and translocation relationships via hPEPT1 of H-X aa-Ser-OH dipeptides: evaluation of H-Phe-Ser-OH as a pro-moiety for ibuprofen and benzoic acid prodrugs.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 77(2), 327-31

Citation

Omkvist, Diana Højmark; Trangbæk, Dennis Jespersen; Mildon, Jemma; Paine, James S; Brodin, Birger; Begtrup, Mikael; Nielsen, Carsten Uhd. (2011). Affinity and translocation relationships via hPEPT1 of H-X aa-Ser-OH dipeptides: evaluation of H-Phe-Ser-OH as a pro-moiety for ibuprofen and benzoic acid prodrugs.. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 77(2), 327-31. https://doi.org/10.1016/j.ejpb.2010.12.009